@mcisaac_d If declared and powered then OK. Fine if labeled exploratory. Most not. See https://t.co/9JbjT1C6XQ
Sig decrease in reporting subgroup analyses with appropriate methods - https://t.co/b1oq21xxm3 Maybe not surprising - but what's to be done?
RT @CGMMaher: No improvement in the reporting of clinical trial subgroup effects in high-impact general medical... https://t.co/BAV281GvZZ…
RT @CGMMaher: No improvement in the reporting of clinical trial subgroup effects in high-impact general medical... https://t.co/BAV281GvZZ…
No improvement in the reporting of clinical trial subgroup effects in high-impact general medical... https://t.co/BAV281GvZZ #trialsjournal
Stratification and Risk indices in clinical trial publications, a few interesting observations by Gabler et ai. https://t.co/DS29uJdLNY
RT @tlassers: Old habits die hard. Reporting results of subgroup analysis in #RCTs shows no sign of improvement https://t.co/xVlJigUNnU
RT @tlassers: Old habits die hard. Reporting results of subgroup analysis in #RCTs shows no sign of improvement https://t.co/xVlJigUNnU
RT @tlassers: Old habits die hard. Reporting results of subgroup analysis in #RCTs shows no sign of improvement https://t.co/xVlJigUNnU
RT @tlassers: Old habits die hard. Reporting results of subgroup analysis in #RCTs shows no sign of improvement https://t.co/xVlJigUNnU
RT @tlassers: Old habits die hard. Reporting results of subgroup analysis in #RCTs shows no sign of improvement https://t.co/xVlJigUNnU
Old habits die hard. Reporting results of subgroup analysis in #RCTs shows no sign of improvement https://t.co/xVlJigUNnU
RT @hildabast: We're not imagining it: subgroup analysis reporting in trials seems to be getting worse 😢 https://t.co/wG4KCVO952 HT @Medic…
RT @CebmOxford: No improvement in reporting of clinical trial subgroup effects in high-impact general med journals https://t.co/jxihxqiyrF…
No improvement in the reporting of clinical trial subgroup effects in high-impact general medical... https://t.co/2d5tnhSJG8 #trialsjournal
RT @glbryson: Subgroup analyses continue to be poorly conducted, and getting worse. https://t.co/OptBwxjNPR #trialsjournal
RT @hildabast: We're not imagining it: subgroup analysis reporting in trials seems to be getting worse 😢 https://t.co/wG4KCVO952 HT @Medic…
RT @danrshan: Statistical methods used for #clinicaltrials sub-group analyses have actually gotten worse over the last 10 years: https://t.…
RT @hildabast: We're not imagining it: subgroup analysis reporting in trials seems to be getting worse 😢 https://t.co/wG4KCVO952 HT @Medic…
We're not imagining it: subgroup analysis reporting in trials seems to be getting worse 😢 https://t.co/wG4KCVO952 HT @MedicalEvidence
No improvement in the reporting of #clinicaltrial subgroup effects in high-impact general medical journals - https://t.co/WhsyWQb6s9
RT @MedicalEvidence: No improvement in reporting of clinical trial subgroup effects in general medical journals - via #Trialsjournal: https…
No improvement in reporting of clinical trial subgroup effects in general medical journals - via #Trialsjournal: https://t.co/yUO2MtLZrH
RT @CebmOxford: No improvement in reporting of clinical trial subgroup effects in high-impact general med journals https://t.co/jxihxqiyrF…
RT @CebmOxford: No improvement in reporting of clinical trial subgroup effects in high-impact general med journals https://t.co/jxihxqiyrF…
No improvement in reporting of clinical trial subgroup effects in high-impact general med journals https://t.co/jxihxqiyrF @BioMedCentral
Subgroup analyses continue to be poorly conducted, and getting worse. https://t.co/OptBwxjNPR #trialsjournal
Statistical methods used for #clinicaltrials sub-group analyses have actually gotten worse over the last 10 years: https://t.co/tT2kL02shk
New research in #Trialsjournal shows suboptimal reporting of subgroup effects: https://t.co/2VOT5CngKv
No improvement in the reporting of clinical trial subgroup effects in high-impact general medical... https://t.co/L5ZgrPJ66d #trialsjournal